Literature DB >> 1308828

The MAIPA assay and its applications in immunohaematology.

V Kiefel1.   

Abstract

The monoclonal antibody immobilization of platelet antigens (MAIPA) assay has proved to be a reliable and useful tool in platelet immunology. After immunochemical localization of the most important platelet allo- and autoantigens on platelet glycoproteins (GPs) IIb/IIIa, Ia/IIa, Ib/IX, the corresponding antibodies can easily be detected with this technique because mAbs against these membrane constituents are now readily available. The assay also allows reliable typing of platelet alloantigens. Detection of GP-specific PAIgG (by direct MAIPA) has proved to be a specific diagnostic sign of AITP. The MAIPA assay allowed identification of 'new' alloantibody specificities including alloantibodies against 'low-frequency' antigens. The principle of this technique has successfully been applied to characterize antibodies against lymphocytes, endothelial cells and granulocytes.

Mesh:

Substances:

Year:  1992        PMID: 1308828     DOI: 10.1111/j.1365-3148.1992.tb00153.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  11 in total

1.  Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins.

Authors:  Mervyn A Sahud; Michael Caulfield; Nigel Clarke; Robert Koch; Daniel Bougie; Richard Aster
Journal:  Br J Haematol       Date:  2013-08-19       Impact factor: 6.998

2.  Establishment of a cell line panel for the detection of antibodies against human platelet antigen 4b.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Masayasu Inoue; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

3.  Laboratory investigation of immune thrombocytopenia.

Authors:  M Warner; J G Kelton
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

4.  Detection of anti-human platelet antibodies against integrin α2β1 using cell lines.

Authors:  Tomoya Hayashi; Etsuko Amakishi; Nobuki Matsuyama; Kazuta Yasui; Rika Ann Furuta; Yuji Hori; Shigenori Tanaka; Yasuo Fukumori; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2012-11-22       Impact factor: 3.443

5.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

Review 6.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

Review 7.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

8.  Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.

Authors:  Behnaz Bayat; Annalena Traum; Heike Berghöfer; Silke Werth; Jieging Zhu; Gregor Bein; Ulrich J Sachs; Sentot Santoso
Journal:  Thromb Haemost       Date:  2019-10-06       Impact factor: 5.249

9.  Timely diagnosis and treatment of neonatal alloimmune thrombocytopenia caused by anti HPA-3a antibody: A case report.

Authors:  Qiankun Yang; Xianping Lv; Yongkui Kong; Xin Liu; Ming Shao; Yanteng Zhao; Namei Xia; Shuya Wang; Huidong Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.

Authors:  Ying-Jan Weng; Anne Husebekk; Björn Skogen; Mette Kjaer; Liang-Tzung Lin; Thierry Burnouf
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.